Identificador persistente para citar o vincular este elemento: https://accedacris.ulpgc.es/handle/10553/140973
Campo DC Valoridioma
dc.contributor.authorGonzález Domínguez, María Del Carmenen_US
dc.contributor.authorFornell-Perez, Robertoen_US
dc.contributor.authorSantana Suarez, Ernestoen_US
dc.contributor.authorRiol Sancho, Diegoen_US
dc.contributor.authorDominguez, Elisabet Gonzalezen_US
dc.contributor.authorLoro Ferrer, Juan Franciscoen_US
dc.date.accessioned2025-06-23T09:04:55Z-
dc.date.available2025-06-23T09:04:55Z-
dc.date.issued2025en_US
dc.identifier.issn1070-3004en_US
dc.identifier.otherWoS-
dc.identifier.urihttps://accedacris.ulpgc.es/handle/10553/140973-
dc.description.abstractObjectives: To evaluate the predictive value of two radiological markers, the spot sign and leakage sign, for spontaneous intracranial hematoma expansion and their association with clinical outcomes, including neurological deterioration and in-hospital mortality. Materials & methods: This prospective single-center study included 94 adult patients with spontaneous intraparenchymal hemorrhagic stroke, confirmed by non-enhanced CT (NECT) and contrast-enhanced CT (CECT) in the arterial phase. Hematoma volumes and spot/leakage signs were assessed using standardized imaging protocols and analyzed by two blinded neuroradiologists. Clinical and radiological data were evaluated using multivariate analyses, with survival outcomes compared via Kaplan-Meier curves. Statistical significance was set at p <= 0.05. Results: Among 94 patients, hematoma expansion occurred in 42%, neurological deterioration in 15.5%, and mortality in 39.4%. The leakage sign was the strongest independent predictor of hematoma expansion (OR: 9.27, 95% CI: 2.95-29.20), neurological deterioration (OR: 26.67, 95% CI: 1.62-47.39), and mortality (OR: 7.56, 95% CI: 2.97-19.25). The spot and leakage signs demonstrated high specificity for predicting outcomes, with the leakage sign showing greater sensitivity for hematoma expansion. Patients with a positive leakage sign had significantly lower median survival (6 days) compared to those with a positive spot sign alone (54 days) or no signs (110 days, p < 0.001). Conclusion: The leakage sign demonstrated greater sensitivity and comparable specificity to the spot sign for predicting hematoma expansion. Both signs were associated with neurological deterioration and in-hospital mortality, with the leakage sign showing a stronger predictive value.en_US
dc.languageengen_US
dc.relation.ispartofEmergency Radiologyen_US
dc.sourceEmergency Radiology [ISSN 1070-3004], (2025)en_US
dc.subject32 Ciencias médicasen_US
dc.subject320111 Radiologíaen_US
dc.subject320507 Neurologíaen_US
dc.subject.otherBlood-Pressure Reductionen_US
dc.subject.otherIntracerebral Hemorrhageen_US
dc.subject.otherComputed-Tomographyen_US
dc.subject.otherGrowthen_US
dc.subject.otherAcute Strokeen_US
dc.subject.otherIntracranial Hemorrhagesen_US
dc.subject.otherComputed Tomographyen_US
dc.subject.otherInhospital Mortalityen_US
dc.subject.otherNeurological Deteriorationen_US
dc.subject.otherPredictive Value Of Testsen_US
dc.titleComparative assessment of the spot sign and leakage sign as predictive factors for spontaneous intracranial hematoma expansionen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1007/s10140-025-02352-3en_US
dc.identifier.isi001507251300001-
dc.identifier.eissn1438-1435-
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.description.numberofpages10en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Domínguez, MDG-
dc.contributor.wosstandardWOS:Fornell-Pérez, R-
dc.contributor.wosstandardWOS:Suárez, ES-
dc.contributor.wosstandardWOS:Sancho, DR-
dc.contributor.wosstandardWOS:Domínguez, EG-
dc.contributor.wosstandardWOS:Loro-Ferrer, JF-
dc.date.coverdate2025en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr0,494
dc.description.sjrqQ2
dc.description.esciESCI
dc.description.miaricds10,0
item.fulltextCon texto completo-
item.grantfulltextopen-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.orcid0000-0002-0517-8209-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameGonzález Domínguez, María Del Carmen-
crisitem.author.fullNameLoro Ferrer, Juan Francisco-
Colección:Artículos
Adobe PDF (1,38 MB)
Vista resumida

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.